
Silakan coba pencarian lain
YTD | 3Bln | 1T | 3Thn | 5T | 10T | |
---|---|---|---|---|---|---|
Pertumbuhan 1000 | 995 | 1055 | 1222 | 2233 | 3145 | 3457 |
Imbal Hasil Dana | -0.47% | 5.48% | 22.24% | 30.71% | 25.76% | 13.21% |
Posisi di kategori | 9 | 63 | 16 | 2 | 4 | 9 |
% di kategori | 7 | 69 | 15 | 2 | 6 | 37 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Reg Div Payout | 756,39B | 11,12 | 17,81 | 12,40 | ||
SBI Magnum Balanced Fund Direct Div | 756,39B | 11,48 | 18,61 | 13,33 | ||
SBI Magnum Balanced Fund Direct Gro | 756,39B | 11,48 | 18,61 | 13,42 | ||
SBI Magnum Balanced Fund Regular Gr | 756,39B | 11,12 | 17,81 | 12,48 | ||
SBI Blue Chip Fund Direct Dividend | 522,51B | 7,57 | 20,06 | 13,66 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Dividend Payout | 83,52B | -2,36 | 25,12 | 15,45 | ||
Reliance Pharma Fund - Growth | 83,52B | -1,55 | 25,78 | 14,50 | ||
Reliance Pharma Direct Bonus | 83,52B | -1,11 | 26,91 | 15,53 | ||
Reliance Pharma Direct Growth | 83,52B | -1,11 | 26,91 | 15,53 |
Nama | ISIN | Bobot % | Terakhir | Perubahan % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12,73 | 1.682,60 | +0,63% | |
Divi's Labs | INE361B01024 | 7,39 | 6.778,50 | -0,83% | |
Max Healthcare Institute | INE027H01010 | 6,40 | 1.249,60 | +2,49% | |
Lonza Group AG | US54338V1017 | 4,81 | 70,58 | -0,20% | |
Cipla | INE059A01026 | 4,77 | 1.484,00 | -0,07% |
Jenis | Harian | Mingguan | Bulanan |
---|---|---|---|
Moving Average | Beli | Beli | Beli |
Indikator Teknikal | Sangat Beli | Sangat Beli | Sangat Beli |
Rangkuman | Sangat Beli | Sangat Beli | Sangat Beli |
Anda yakin ingin memblokir %USER_NAME%?
Jika ya, Anda dan %USER_NAME% tidak akan dapat melihat posting satu sama lain di Investing.com.
%USER_NAME% berhasil dimasukkan ke Daftar Blokir Anda
Karena Anda baru saja membatalkan blokir pengguna ini, Anda harus menunggu 48 jam sebelum kembali memblokir.
Menurut saya, komentar ini:
Terima Kasih!
Laporan Anda telah terkirim untuk ditinjau oleh moderator kami